• No results found

Grant of Permission

N/A
N/A
Protected

Academic year: 2022

Share "Grant of Permission"

Copied!
3
0
0

Loading.... (view fulltext now)

Full text

(1)

PS - 2010 - 0028 RY - 2010 - 0028 MMS Reference Number:

MMS Invoice Number:

The Publishing Division

of the Massachusetts Medical Society Publishers of

The New England Journal of Medicine, Journal Watch Newsletters,

& AIDS Clinical Care

Grant of Permission

June 04, 2009

Mr. Groom Alemayehu Uppsala Universitet Svartbacksgatan 83 B Uppsala, 018 75333 Sweden

Dear Mr. Alemayehu,

Thank you for your interest in our copyrighted material, and for requesting permission for its use.

Permission is granted for limited, non-exclusive educational use of the material requested, subject to all the terms and conditions outlined throughout this document. Please review all of the following pages, including the "Basic Provisions of Grant of Permission" as well as "Items Covered by Grant of Permission." A Permissions Invoice is included as the last page, if applicable.

Thank you for your patience while your request was being processed. If you wish to contact us further, please use the address below, and cite our reference numbers on any correspondence.

Sincerely, Jennifer Moran

Sr. Rights & Permissions Representative

Publishing Division of the Massachusetts Medical Society Department of Permissions & Licensing

860 Winter Street, Waltham, Massachusetts 02451-1413 USA Tel: (781) 434 7382 · Fax: (781) 434 7633 · permissions@nejm.org

Page 1

(2)

Items Covered by Grant of Permission

MMS Reference Number:

PS - 2010 - 0028 RY - 2010 - 0028

MMS Invoice Number: Source InformationFurther Conditions CustomerSource:The New England Journal of Medicine Pub. DateAuthor(s)Article TitleAdaptedLanguageFormatPages

- Dollar AmountItemReferenceVolumeType

Telephone: (781) 434-7382 fax: (781) 434-7633860 Winter Street, Waltham, Massachusetts 02451-1413 USADepartment of Permissions & Licensing

of the Massachusetts Medical SocietyThe Publishing Division F1Print & ElectronicNSwedish- 349 0.00Nuclear Transplantation, Embryonic Stem Cells, and the Potential for Cell TheraHochedlinger, Jaenisch7/17/2003

F

275 286 The following information has been provided for us in your letter of request.

End Use: Thesis on embryonic stem cell research User: Sponsor: Date of Use: Number of Copies:

Groom Alemayehu Uppsala University 2009 1

Page 3 - A - Abstract, F - Figure, FT-Full Text, I - Images in Clinical Medicine, T - Table, Q - Excerpt/Quote

(3)

Items Covered by Grant of Permission

MMS Reference Number:

PS - 2010 - 0028 RY - 2010 - 0028

MMS Invoice Number: Source InformationFurther Conditions CustomerSource:The New England Journal of Medicine Pub. DateAuthor(s)Article TitleAdaptedLanguageFormatPages

- Dollar AmountItemReferenceVolumeType

Telephone: (781) 434-7382 fax: (781) 434-7633860 Winter Street, Waltham, Massachusetts 02451-1413 USADepartment of Permissions & Licensing

of the Massachusetts Medical SocietyThe Publishing Division F1Print & ElectronicNSwedish- 349 0.00Nuclear Transplantation, Embryonic Stem Cells, and the Potential for Cell TheraHochedlinger, Jaenisch7/17/2003

F

275 286 The following information has been provided for us in your letter of request.

End Use: Thesis on embryonic stem cell research User: Sponsor: Date of Use: Number of Copies:

Groom Alemayehu Uppsala University 2009 1

Page 3 - A - Abstract, F - Figure, FT-Full Text, I - Images in Clinical Medicine, T - Table, Q - Excerpt/Quote

References

Related documents

The two aspects of Hippo pathway function we are interested in include the mES cell self-renewal and cell-to-cell contact inhibition.. Interestingly, The Hippo core components are

residing in the bone marrow , human MSCs (hMSCs) have historically been the main source of cells for bone engineering applications. hMSCs are multipotent stem

Giuseppe Maria de Peppo, Anders Palmquist, Peter Borchardt, Maria Lennerås, Johan Hyllner, Anders Snis, Jukkaa Lausmaa, Peter Thomsen, Camilla Karlsson.. HUMAN

In paper IV we found that MSCs up-regulated their gene expression of BMP2 and RUNX2 in response to signal secreted from LPS- activated MO and in paper V it

Keywords: Mesenchymal stem cells, mesenchymal stromal cells, osteogenic differentiation, adipogenic differentiation, bone regeneration, inflammation, monocytes,

Acute graft-versus-host disease (GVHD), relapse and graft rejection are the main complications after allogeneic hematopoietic stem cell transplantation (HSCT).. The aim of this

Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and

Comparing expression of the markers on different strategies the application of stem cells treated Cornea sections were not positive for any of the markers applied in